Vanguard Group Inc Ocular Therapeutix, Inc Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 8,392,175 shares of OCUL stock, worth $107 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,392,175
Previous 8,364,515 0.33%
Holding current value
$107 Million
Previous $61.3 Million 27.02%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$6.02 - $9.46 $166,513 - $261,663
27,660 Added 0.33%
8,392,175 $77.9 Million
Q1 2025

May 09, 2025
SELL
$5.93 - $9.08 $708,030 - $1.08 Million
-119,398 Reduced 1.41%
8,364,515 $61.3 Million
Q4 2024

Feb 11, 2025
BUY
$8.33 - $11.47 $830,750 - $1.14 Million
99,730 Added 1.19%
8,483,913 $72.5 Million
Q3 2024

Nov 13, 2024
SELL
$6.45 - $9.23 $1.47 Million - $2.1 Million
-227,918 Reduced 2.65%
8,384,183 $72.9 Million
Q2 2024

Aug 13, 2024
BUY
$4.2 - $8.69 $5.78 Million - $12 Million
1,376,970 Added 19.03%
8,612,101 $58.9 Million
Q1 2024

May 10, 2024
BUY
$3.85 - $10.93 $8.15 Million - $23.1 Million
2,117,029 Added 41.36%
7,235,131 $65.8 Million
Q4 2023

Feb 14, 2024
BUY
$2.08 - $4.52 $2.2 Million - $4.78 Million
1,057,123 Added 26.03%
5,118,102 $22.8 Million
Q3 2023

Nov 14, 2023
BUY
$3.14 - $5.04 $25,597 - $41,086
8,152 Added 0.2%
4,060,979 $12.8 Million
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $52,610 - $87,378
11,437 Added 0.28%
4,052,827 $20.9 Million
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $180,058 - $404,646
64,537 Added 1.62%
4,041,390 $21.3 Million
Q4 2022

Feb 10, 2023
BUY
$2.61 - $4.41 $65,372 - $110,457
25,047 Added 0.63%
3,976,853 $11.2 Million
Q3 2022

Nov 14, 2022
BUY
$4.09 - $6.5 $217,812 - $346,157
53,255 Added 1.37%
3,951,806 $16.4 Million
Q2 2022

Aug 12, 2022
SELL
$3.01 - $5.22 $893,533 - $1.55 Million
-296,855 Reduced 7.08%
3,898,551 $15.7 Million
Q1 2022

May 13, 2022
BUY
$4.83 - $7.35 $562,129 - $855,415
116,383 Added 2.85%
4,195,406 $20.8 Million
Q4 2021

Feb 14, 2022
BUY
$6.16 - $12.07 $2.43 Million - $4.76 Million
394,174 Added 10.7%
4,079,023 $28.4 Million
Q3 2021

Nov 12, 2021
BUY
$9.7 - $14.34 $154,074 - $227,776
15,884 Added 0.43%
3,684,849 $36.8 Million
Q2 2021

Aug 13, 2021
BUY
$13.43 - $19.16 $49.3 Million - $70.3 Million
3,668,965 New
3,668,965 $52 Million

Others Institutions Holding OCUL

# of Institutions
203
Shares Held
137M
Call Options Held
743K
Put Options Held
321K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $978M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email